PPA
TRIB

Parametric Portfolio Associates’s Trinity Biotech TRIB Stock Holding History

Parametric Portfolio Associates’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,534
Closed -$1.29M – 3943
2017
Q3 		$1.29M Buy
1,534
+10
+0.7% +$8.37K ﹤0.01% 2885
2017
Q2 		$1.37M Buy
1,524
+1
+0.1% +$850 ﹤0.01% 2796
2017
Q1 		$1.36M Buy
1,523
+1
+0.1% +$938 ﹤0.01% 2701
2016
Q4 		$1.58M Sell
1,522
-180
-11% -$186K ﹤0.01% 2542
2016
Q3 		$3.38M Hold
1,702
– – 0.01% 1931
2016
Q2 		$2.9M Buy
1,702
+104
+7% +$176K ﹤0.01% 2028
2016
Q1 		$2.79M Buy
+1,598
New +$2.54M ﹤0.01% 2115

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Parametric Portfolio Associates's TRIB Position: Q4 2017 in Review

Parametric Portfolio Associates sold out of Trinity Biotech (TRIB) in Q4 2017, closing a stake of 1,534 shares — an estimated $1.29M sold.

Parametric Portfolio Associates first reported a position in TRIB in Q1 2016 and held it in 7 quarters. The position peaked at $3.38M in Q3 2016. 47 funds tracked by Wall St. Rank hold TRIB as of Q4 2017.

  • Parametric Portfolio Associates reported no remaining Trinity Biotech position as of Q4 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,534 Trinity Biotech shares in Q4 2017, an estimated $1.29M.
  • Parametric Portfolio Associates first reported a position in Trinity Biotech in Q1 2016 and held it in 7 quarters.
  • Parametric Portfolio Associates's Trinity Biotech position peaked at $3.38M in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2017.

Based on Parametric Portfolio Associates's 13F filing for Q4 2017, filed 14 Feb 2018.